The UK pharmaceutical intermediate market is on a steady growth trajectory, expected to reach USD 1,156.0 million in 2025 and expand to USD 1,553.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 3.0% over the forecast period from 2025 to 2035. The sector’s expansion is being driven by increasing innovation in active …